nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MUT—parathyroid gland—thyroid cancer	0.044	0.139	CbGeAlD
Hydroxocobalamin—Chromaturia—Vandetanib—thyroid cancer	0.0185	0.0559	CcSEcCtD
Hydroxocobalamin—TCN1—saliva-secreting gland—thyroid cancer	0.0147	0.0466	CbGeAlD
Hydroxocobalamin—MUT—neck—thyroid cancer	0.0133	0.0422	CbGeAlD
Hydroxocobalamin—MMACHC—head—thyroid cancer	0.0128	0.0405	CbGeAlD
Hydroxocobalamin—TCN1—trachea—thyroid cancer	0.0114	0.036	CbGeAlD
Hydroxocobalamin—Folliculitis—Vandetanib—thyroid cancer	0.0105	0.0318	CcSEcCtD
Hydroxocobalamin—MUT—saliva-secreting gland—thyroid cancer	0.0104	0.0329	CbGeAlD
Hydroxocobalamin—CUBN—thyroid gland—thyroid cancer	0.00997	0.0316	CbGeAlD
Hydroxocobalamin—MMAA—thyroid gland—thyroid cancer	0.00943	0.0299	CbGeAlD
Hydroxocobalamin—MTRR—saliva-secreting gland—thyroid cancer	0.00934	0.0296	CbGeAlD
Hydroxocobalamin—TCN1—thyroid gland—thyroid cancer	0.00898	0.0285	CbGeAlD
Hydroxocobalamin—MMAB—thyroid gland—thyroid cancer	0.00884	0.028	CbGeAlD
Hydroxocobalamin—MMAA—head—thyroid cancer	0.00837	0.0265	CbGeAlD
Hydroxocobalamin—CASP9—thyroid gland—thyroid cancer	0.00826	0.0262	CbGeAlD
Hydroxocobalamin—MTR—saliva-secreting gland—thyroid cancer	0.00815	0.0258	CbGeAlD
Hydroxocobalamin—TCN2—thyroid gland—thyroid cancer	0.00807	0.0256	CbGeAlD
Hydroxocobalamin—MUT—trachea—thyroid cancer	0.00802	0.0254	CbGeAlD
Hydroxocobalamin—TCN1—head—thyroid cancer	0.00797	0.0253	CbGeAlD
Hydroxocobalamin—MMAB—head—thyroid cancer	0.00785	0.0249	CbGeAlD
Hydroxocobalamin—AMN—lymph node—thyroid cancer	0.00736	0.0233	CbGeAlD
Hydroxocobalamin—CASP9—head—thyroid cancer	0.00733	0.0232	CbGeAlD
Hydroxocobalamin—MTRR—trachea—thyroid cancer	0.0072	0.0228	CbGeAlD
Hydroxocobalamin—TCN2—head—thyroid cancer	0.00716	0.0227	CbGeAlD
Hydroxocobalamin—Folliculitis—Sorafenib—thyroid cancer	0.00711	0.0214	CcSEcCtD
Hydroxocobalamin—MUT—thyroid gland—thyroid cancer	0.00634	0.0201	CbGeAlD
Hydroxocobalamin—MTR—trachea—thyroid cancer	0.00628	0.0199	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—thyroid cancer	0.0062	0.0196	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—thyroid cancer	0.00586	0.0186	CbGeAlD
Hydroxocobalamin—Pleural effusion—Sorafenib—thyroid cancer	0.00584	0.0176	CcSEcCtD
Hydroxocobalamin—MTRR—thyroid gland—thyroid cancer	0.0057	0.0181	CbGeAlD
Hydroxocobalamin—MUT—head—thyroid cancer	0.00563	0.0178	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—thyroid cancer	0.00549	0.0174	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—thyroid cancer	0.00513	0.0163	CbGeAlD
Hydroxocobalamin—MTRR—head—thyroid cancer	0.00506	0.016	CbGeAlD
Hydroxocobalamin—Dermatitis bullous—Vandetanib—thyroid cancer	0.00503	0.0152	CcSEcCtD
Hydroxocobalamin—TCN2—lymph node—thyroid cancer	0.00501	0.0159	CbGeAlD
Hydroxocobalamin—MTR—thyroid gland—thyroid cancer	0.00497	0.0158	CbGeAlD
Hydroxocobalamin—Hyponatraemia—Vandetanib—thyroid cancer	0.00483	0.0146	CcSEcCtD
Hydroxocobalamin—Sensitisation—Epirubicin—thyroid cancer	0.00462	0.0139	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Vandetanib—thyroid cancer	0.00457	0.0138	CcSEcCtD
Hydroxocobalamin—Blood pressure increased—Sorafenib—thyroid cancer	0.00447	0.0135	CcSEcCtD
Hydroxocobalamin—MTR—head—thyroid cancer	0.00441	0.014	CbGeAlD
Hydroxocobalamin—Hypokalaemia—Vandetanib—thyroid cancer	0.00438	0.0132	CcSEcCtD
Hydroxocobalamin—Sensitisation—Doxorubicin—thyroid cancer	0.00428	0.0129	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Epirubicin—thyroid cancer	0.00418	0.0126	CcSEcCtD
Hydroxocobalamin—Dysphagia—Vandetanib—thyroid cancer	0.00416	0.0125	CcSEcCtD
Hydroxocobalamin—Haematochezia—Epirubicin—thyroid cancer	0.0041	0.0124	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—thyroid cancer	0.00394	0.0125	CbGeAlD
Hydroxocobalamin—Bullous eruption—Doxorubicin—thyroid cancer	0.00387	0.0117	CcSEcCtD
Hydroxocobalamin—Haematochezia—Doxorubicin—thyroid cancer	0.00379	0.0114	CcSEcCtD
Hydroxocobalamin—Eczema—Sorafenib—thyroid cancer	0.00361	0.0109	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00358	0.0108	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—thyroid cancer	0.00354	0.0112	CbGeAlD
Hydroxocobalamin—Urinary tract disorder—Vandetanib—thyroid cancer	0.00329	0.0099	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Vandetanib—thyroid cancer	0.00326	0.00983	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Sorafenib—thyroid cancer	0.00326	0.00982	CcSEcCtD
Hydroxocobalamin—Eye disorder—Vandetanib—thyroid cancer	0.00311	0.00937	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—thyroid cancer	0.00309	0.00979	CbGeAlD
Hydroxocobalamin—Cardiac disorder—Vandetanib—thyroid cancer	0.00309	0.0093	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Epirubicin—thyroid cancer	0.00306	0.00922	CcSEcCtD
Hydroxocobalamin—Angiopathy—Vandetanib—thyroid cancer	0.00302	0.0091	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vandetanib—thyroid cancer	0.003	0.00904	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Vandetanib—thyroid cancer	0.00297	0.00896	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Sorafenib—thyroid cancer	0.00295	0.0089	CcSEcCtD
Hydroxocobalamin—Mental disorder—Vandetanib—thyroid cancer	0.00291	0.00878	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—thyroid cancer	0.00283	0.00853	CcSEcCtD
Hydroxocobalamin—Dysphagia—Sorafenib—thyroid cancer	0.0028	0.00845	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Sorafenib—thyroid cancer	0.00269	0.0081	CcSEcCtD
Hydroxocobalamin—Folliculitis—Epirubicin—thyroid cancer	0.00263	0.00792	CcSEcCtD
Hydroxocobalamin—Chest pain—Vandetanib—thyroid cancer	0.00247	0.00743	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00245	0.00738	CcSEcCtD
Hydroxocobalamin—Redness—Epirubicin—thyroid cancer	0.00245	0.00737	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—thyroid cancer	0.00243	0.00733	CcSEcCtD
Hydroxocobalamin—Oedema—Vandetanib—thyroid cancer	0.00236	0.00712	CcSEcCtD
Hydroxocobalamin—Infection—Vandetanib—thyroid cancer	0.00235	0.00708	CcSEcCtD
Hydroxocobalamin—Lung disorder—Epirubicin—thyroid cancer	0.00233	0.00703	CcSEcCtD
Hydroxocobalamin—Thrombosis—Epirubicin—thyroid cancer	0.00233	0.00703	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vandetanib—thyroid cancer	0.00232	0.00699	CcSEcCtD
Hydroxocobalamin—Skin disorder—Vandetanib—thyroid cancer	0.0023	0.00692	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—thyroid cancer	0.00226	0.00682	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00222	0.00668	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Sorafenib—thyroid cancer	0.0022	0.00663	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—thyroid cancer	0.00216	0.00651	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—thyroid cancer	0.00216	0.00651	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Epirubicin—thyroid cancer	0.00216	0.0065	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Vandetanib—thyroid cancer	0.00211	0.00635	CcSEcCtD
Hydroxocobalamin—Feeling hot—Epirubicin—thyroid cancer	0.0021	0.00634	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Sorafenib—thyroid cancer	0.00208	0.00628	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Vandetanib—thyroid cancer	0.00208	0.00627	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00204	0.00615	CcSEcCtD
Hydroxocobalamin—Angiopathy—Sorafenib—thyroid cancer	0.00204	0.00614	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Sorafenib—thyroid cancer	0.00203	0.00611	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Sorafenib—thyroid cancer	0.00202	0.0061	CcSEcCtD
Hydroxocobalamin—Pain—Vandetanib—thyroid cancer	0.00202	0.00609	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Sorafenib—thyroid cancer	0.002	0.00604	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—thyroid cancer	0.002	0.00601	CcSEcCtD
Hydroxocobalamin—Mental disorder—Sorafenib—thyroid cancer	0.00197	0.00593	CcSEcCtD
Hydroxocobalamin—Erythema—Sorafenib—thyroid cancer	0.00195	0.00589	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—thyroid cancer	0.00195	0.00587	CcSEcCtD
Hydroxocobalamin—Extravasation—Epirubicin—thyroid cancer	0.00189	0.0057	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vandetanib—thyroid cancer	0.00187	0.00563	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00183	0.00551	CcSEcCtD
Hydroxocobalamin—Angioedema—Sorafenib—thyroid cancer	0.00179	0.00538	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—thyroid cancer	0.00175	0.00528	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00169	0.0051	CcSEcCtD
Hydroxocobalamin—Pruritus—Vandetanib—thyroid cancer	0.00167	0.00504	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00165	0.00498	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—thyroid cancer	0.00164	0.00495	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vandetanib—thyroid cancer	0.00162	0.00487	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00159	0.0048	CcSEcCtD
Hydroxocobalamin—Infection—Sorafenib—thyroid cancer	0.00158	0.00477	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Sorafenib—thyroid cancer	0.00156	0.00471	CcSEcCtD
Hydroxocobalamin—Dizziness—Vandetanib—thyroid cancer	0.00156	0.00471	CcSEcCtD
Hydroxocobalamin—Skin disorder—Sorafenib—thyroid cancer	0.00155	0.00467	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—thyroid cancer	0.00152	0.00458	CcSEcCtD
Hydroxocobalamin—Rash—Vandetanib—thyroid cancer	0.00149	0.00449	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vandetanib—thyroid cancer	0.00149	0.00449	CcSEcCtD
Hydroxocobalamin—Headache—Vandetanib—thyroid cancer	0.00148	0.00446	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—thyroid cancer	0.00147	0.00443	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Sorafenib—thyroid cancer	0.00142	0.00428	CcSEcCtD
Hydroxocobalamin—Nausea—Vandetanib—thyroid cancer	0.0014	0.00423	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Sorafenib—thyroid cancer	0.0014	0.00423	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—thyroid cancer	0.00139	0.00419	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00138	0.00415	CcSEcCtD
Hydroxocobalamin—Pain—Sorafenib—thyroid cancer	0.00136	0.00411	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00136	0.0041	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—thyroid cancer	0.00133	0.00402	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00132	0.00398	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—thyroid cancer	0.00129	0.00388	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—thyroid cancer	0.00128	0.00386	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—thyroid cancer	0.00127	0.00383	CcSEcCtD
Hydroxocobalamin—Urticaria—Sorafenib—thyroid cancer	0.00127	0.00382	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Sorafenib—thyroid cancer	0.00126	0.0038	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—thyroid cancer	0.00125	0.00378	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—thyroid cancer	0.00123	0.00372	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00122	0.00369	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—thyroid cancer	0.0012	0.00363	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—thyroid cancer	0.00119	0.00357	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00118	0.00354	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sorafenib—thyroid cancer	0.00117	0.00354	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00116	0.0035	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—thyroid cancer	0.00114	0.00344	CcSEcCtD
Hydroxocobalamin—Pruritus—Sorafenib—thyroid cancer	0.00113	0.0034	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—thyroid cancer	0.00111	0.00336	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—thyroid cancer	0.00109	0.00329	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sorafenib—thyroid cancer	0.00109	0.00329	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—thyroid cancer	0.00105	0.00318	CcSEcCtD
Hydroxocobalamin—Dizziness—Sorafenib—thyroid cancer	0.00105	0.00318	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—thyroid cancer	0.00104	0.00312	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—thyroid cancer	0.00101	0.00304	CcSEcCtD
Hydroxocobalamin—Rash—Sorafenib—thyroid cancer	0.00101	0.00303	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sorafenib—thyroid cancer	0.001	0.00303	CcSEcCtD
Hydroxocobalamin—Headache—Sorafenib—thyroid cancer	0.000999	0.00301	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—thyroid cancer	0.000959	0.00289	CcSEcCtD
Hydroxocobalamin—Nausea—Sorafenib—thyroid cancer	0.000947	0.00285	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000819	0.00247	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—thyroid cancer	0.000817	0.00246	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—thyroid cancer	0.000813	0.00245	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—thyroid cancer	0.000775	0.00234	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—thyroid cancer	0.00077	0.00232	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000758	0.00228	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000756	0.00228	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—thyroid cancer	0.000752	0.00227	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—thyroid cancer	0.000752	0.00227	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—thyroid cancer	0.000749	0.00226	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000747	0.00225	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—thyroid cancer	0.000744	0.00224	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—thyroid cancer	0.000741	0.00223	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—thyroid cancer	0.000727	0.00219	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—thyroid cancer	0.000722	0.00218	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—thyroid cancer	0.000717	0.00216	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000712	0.00215	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—thyroid cancer	0.000696	0.0021	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—thyroid cancer	0.000693	0.00209	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000692	0.00208	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—thyroid cancer	0.000689	0.00208	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—thyroid cancer	0.000686	0.00207	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—thyroid cancer	0.000672	0.00203	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—thyroid cancer	0.00067	0.00202	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—thyroid cancer	0.000668	0.00201	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—thyroid cancer	0.000663	0.002	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—thyroid cancer	0.000651	0.00196	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00062	0.00187	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—thyroid cancer	0.000615	0.00185	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—thyroid cancer	0.000614	0.00185	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00061	0.00184	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—thyroid cancer	0.000607	0.00183	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—thyroid cancer	0.000602	0.00182	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000589	0.00178	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—thyroid cancer	0.000589	0.00178	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—thyroid cancer	0.000585	0.00176	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—thyroid cancer	0.000578	0.00174	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—thyroid cancer	0.000575	0.00173	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—thyroid cancer	0.000572	0.00172	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—thyroid cancer	0.000569	0.00171	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000565	0.0017	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—thyroid cancer	0.000562	0.00169	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000545	0.00164	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—thyroid cancer	0.000545	0.00164	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—thyroid cancer	0.000542	0.00163	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000535	0.00161	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—thyroid cancer	0.000532	0.0016	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—thyroid cancer	0.00053	0.0016	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—thyroid cancer	0.000525	0.00158	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—thyroid cancer	0.000519	0.00156	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000509	0.00153	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—thyroid cancer	0.000504	0.00152	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—thyroid cancer	0.000486	0.00146	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—thyroid cancer	0.000486	0.00146	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—thyroid cancer	0.00048	0.00145	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000471	0.00142	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—thyroid cancer	0.000468	0.00141	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—thyroid cancer	0.000466	0.00141	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—thyroid cancer	0.000466	0.0014	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000449	0.00135	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—thyroid cancer	0.000434	0.00131	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—thyroid cancer	0.000433	0.00131	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—thyroid cancer	0.000431	0.0013	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—thyroid cancer	0.000417	0.00126	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—thyroid cancer	0.000403	0.00121	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000402	0.00121	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—thyroid cancer	0.00039	0.00117	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—thyroid cancer	0.000386	0.00116	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—thyroid cancer	0.000373	0.00112	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—thyroid cancer	0.000372	0.00112	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—thyroid cancer	0.000371	0.00112	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—thyroid cancer	0.000369	0.00111	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—thyroid cancer	0.000361	0.00109	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—thyroid cancer	0.00035	0.00105	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—thyroid cancer	0.000344	0.00104	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—thyroid cancer	0.000343	0.00104	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—thyroid cancer	0.000342	0.00103	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—thyroid cancer	0.000324	0.000976	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—PRKAR1A—thyroid cancer	0.000301	0.000853	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TPR—thyroid cancer	0.000298	0.000844	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KRAS—thyroid cancer	0.000297	0.000842	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRG1—thyroid cancer	0.000297	0.000841	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NRAS—thyroid cancer	0.000296	0.000839	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KRAS—thyroid cancer	0.000295	0.000838	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—LGALS3—thyroid cancer	0.000295	0.000837	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KRAS—thyroid cancer	0.000294	0.000834	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PRKAR1A—thyroid cancer	0.000293	0.000831	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KRAS—thyroid cancer	0.000293	0.00083	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HIF1A—thyroid cancer	0.000289	0.00082	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HIF1A—thyroid cancer	0.000289	0.00082	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—BRAF—thyroid cancer	0.000289	0.00082	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—BRAF—thyroid cancer	0.000289	0.00082	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TERT—thyroid cancer	0.000289	0.000818	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000288	0.000818	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—RXRA—thyroid cancer	0.000287	0.000815	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000287	0.000814	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.000283	0.000803	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SLC5A5—thyroid cancer	0.000281	0.000796	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000281	0.000796	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000279	0.000792	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRG1—thyroid cancer	0.000278	0.000788	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000278	0.000788	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HIF1A—thyroid cancer	0.000276	0.000783	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000275	0.00078	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000275	0.00078	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KRAS—thyroid cancer	0.000275	0.00078	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TPR—thyroid cancer	0.000275	0.000779	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CALCA—thyroid cancer	0.000273	0.000775	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—KRAS—thyroid cancer	0.000273	0.000773	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—thyroid cancer	0.000272	0.000771	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PPARG—thyroid cancer	0.000272	0.000771	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PRKAR1A—thyroid cancer	0.00027	0.000767	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.00027	0.000767	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KRAS—thyroid cancer	0.000269	0.000763	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—BRAF—thyroid cancer	0.000269	0.000762	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000269	0.000761	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRG1—thyroid cancer	0.000267	0.000757	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TERT—thyroid cancer	0.000266	0.000755	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—HRAS—thyroid cancer	0.000264	0.000749	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TCF7L1—thyroid cancer	0.000263	0.000746	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000259	0.000734	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MEN1—thyroid cancer	0.000259	0.000733	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTGS2—thyroid cancer	0.000255	0.000724	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—thyroid cancer	0.000255	0.000723	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HIF1A—thyroid cancer	0.000255	0.000722	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KRAS—thyroid cancer	0.000255	0.000722	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—HRAS—thyroid cancer	0.000252	0.000716	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—HRAS—thyroid cancer	0.000251	0.000712	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—HRAS—thyroid cancer	0.00025	0.000709	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HRAS—thyroid cancer	0.000249	0.000705	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PPARG—thyroid cancer	0.000249	0.000705	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PPARG—thyroid cancer	0.000249	0.000705	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000248	0.000703	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDK1—thyroid cancer	0.000247	0.000702	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000245	0.000695	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—PTEN—thyroid cancer	0.000244	0.000692	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.000244	0.000691	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRG1—thyroid cancer	0.000244	0.000691	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—BRAF—thyroid cancer	0.00024	0.000679	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—BRAF—thyroid cancer	0.00024	0.000679	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.000237	0.000672	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—RXRA—thyroid cancer	0.000236	0.000669	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000235	0.000665	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000234	0.000663	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000234	0.000663	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HRAS—thyroid cancer	0.000234	0.000663	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—thyroid cancer	0.000234	0.000662	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—thyroid cancer	0.000234	0.000662	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—AKT1—thyroid cancer	0.000233	0.000662	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—HRAS—thyroid cancer	0.000232	0.000657	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PPARG—thyroid cancer	0.000231	0.000655	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00023	0.000653	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.00023	0.000652	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—AKT1—thyroid cancer	0.00023	0.000651	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SLC5A5—thyroid cancer	0.000229	0.000649	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—thyroid cancer	0.000229	0.000649	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—BRAF—thyroid cancer	0.000229	0.000648	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—AKT1—thyroid cancer	0.000223	0.000632	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTEN—thyroid cancer	0.000223	0.000632	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—AKT1—thyroid cancer	0.000222	0.000629	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—AKT1—thyroid cancer	0.000221	0.000626	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—AKT1—thyroid cancer	0.00022	0.000623	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TERT—thyroid cancer	0.000219	0.00062	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—thyroid cancer	0.000218	0.000618	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—thyroid cancer	0.000217	0.000616	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—thyroid cancer	0.000217	0.000614	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.000216	0.000614	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—AKT1—thyroid cancer	0.000215	0.000611	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—thyroid cancer	0.000214	0.000606	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—BRAF—thyroid cancer	0.000211	0.000598	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HIF1A—thyroid cancer	0.000209	0.000593	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000207	0.000588	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000207	0.000586	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—AKT1—thyroid cancer	0.000207	0.000586	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000207	0.000586	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PPARG—thyroid cancer	0.000206	0.000584	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PPARG—thyroid cancer	0.000206	0.000584	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CALCA—thyroid cancer	0.000206	0.000584	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—thyroid cancer	0.000205	0.000581	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTEN—thyroid cancer	0.000204	0.000578	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTEN—thyroid cancer	0.000204	0.000578	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000203	0.000575	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—thyroid cancer	0.000202	0.000573	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDK1—thyroid cancer	0.000202	0.000572	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—thyroid cancer	0.000199	0.000563	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRG1—thyroid cancer	0.000199	0.000563	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PPARG—thyroid cancer	0.000197	0.000557	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—thyroid cancer	0.000196	0.000555	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—thyroid cancer	0.000196	0.000555	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000194	0.000551	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNA2—thyroid cancer	0.000194	0.00055	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—thyroid cancer	0.000194	0.000549	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—thyroid cancer	0.000194	0.000549	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSHR—thyroid cancer	0.000193	0.000546	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—RXRA—thyroid cancer	0.000192	0.000545	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—thyroid cancer	0.000191	0.000542	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKAR1A—thyroid cancer	0.000189	0.000537	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTEN—thyroid cancer	0.000189	0.000537	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—thyroid cancer	0.000188	0.000532	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTEN—thyroid cancer	0.000187	0.000529	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDK1—thyroid cancer	0.000186	0.000528	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—thyroid cancer	0.000185	0.000524	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000183	0.000519	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—thyroid cancer	0.000182	0.000516	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—thyroid cancer	0.000182	0.000515	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—thyroid cancer	0.000182	0.000515	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—thyroid cancer	0.000181	0.000514	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MEN1—thyroid cancer	0.000181	0.000513	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TERT—thyroid cancer	0.000178	0.000506	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—BRAF—thyroid cancer	0.000173	0.000491	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—thyroid cancer	0.000171	0.000485	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTEN—thyroid cancer	0.000171	0.000484	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTEN—thyroid cancer	0.000171	0.000484	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HIF1A—thyroid cancer	0.000171	0.000484	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—thyroid cancer	0.00017	0.000483	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—thyroid cancer	0.000169	0.000479	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTEN—thyroid cancer	0.000169	0.000479	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTEN—thyroid cancer	0.000169	0.000479	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTCH1—thyroid cancer	0.000164	0.000464	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—thyroid cancer	0.000162	0.00046	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—thyroid cancer	0.000162	0.00046	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRG1—thyroid cancer	0.000162	0.000459	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—thyroid cancer	0.000161	0.000457	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—thyroid cancer	0.000159	0.000452	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—thyroid cancer	0.000159	0.00045	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—thyroid cancer	0.000156	0.000444	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—thyroid cancer	0.000156	0.000444	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—thyroid cancer	0.000155	0.000438	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—thyroid cancer	0.000151	0.000427	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—thyroid cancer	0.000151	0.000427	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SST—thyroid cancer	0.00015	0.000424	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRG1—thyroid cancer	0.00015	0.000424	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—thyroid cancer	0.000149	0.000422	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—thyroid cancer	0.000149	0.000421	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—thyroid cancer	0.000145	0.000412	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—thyroid cancer	0.000145	0.000412	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CALCA—thyroid cancer	0.000144	0.000409	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—thyroid cancer	0.000144	0.000407	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—thyroid cancer	0.000143	0.000405	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—thyroid cancer	0.000141	0.000401	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—thyroid cancer	0.000141	0.000401	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—thyroid cancer	0.000141	0.0004	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—thyroid cancer	0.000141	0.000399	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—thyroid cancer	0.00014	0.000397	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—thyroid cancer	0.000139	0.000395	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—thyroid cancer	0.000135	0.000382	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—thyroid cancer	0.000134	0.000381	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—thyroid cancer	0.000134	0.000379	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—thyroid cancer	0.000133	0.000377	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—thyroid cancer	0.000133	0.000377	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—thyroid cancer	0.000133	0.000376	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDK1—thyroid cancer	0.00013	0.00037	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—thyroid cancer	0.00013	0.000367	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—thyroid cancer	0.00013	0.000367	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—thyroid cancer	0.000128	0.000364	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—thyroid cancer	0.000128	0.000364	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—thyroid cancer	0.000124	0.000353	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—thyroid cancer	0.000124	0.000352	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—thyroid cancer	0.000124	0.000351	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—thyroid cancer	0.000124	0.00035	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—thyroid cancer	0.000122	0.000346	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—thyroid cancer	0.000121	0.000344	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—thyroid cancer	0.000119	0.000338	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—thyroid cancer	0.000117	0.000333	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—thyroid cancer	0.000117	0.000333	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—thyroid cancer	0.000117	0.000332	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—thyroid cancer	0.000114	0.000324	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—thyroid cancer	0.000114	0.000323	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—thyroid cancer	0.00011	0.000312	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—thyroid cancer	0.00011	0.000312	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—thyroid cancer	0.000109	0.000309	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—thyroid cancer	0.000109	0.000309	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—thyroid cancer	0.000108	0.000305	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—thyroid cancer	0.000107	0.000303	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—thyroid cancer	0.000106	0.000301	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—thyroid cancer	0.000105	0.000298	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRG1—thyroid cancer	0.000105	0.000297	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—thyroid cancer	0.000103	0.000291	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—thyroid cancer	0.000102	0.00029	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—thyroid cancer	9.95e-05	0.000282	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—thyroid cancer	9.83e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—thyroid cancer	9.83e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—thyroid cancer	9.73e-05	0.000276	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—thyroid cancer	9.73e-05	0.000276	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—thyroid cancer	9.7e-05	0.000275	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—thyroid cancer	9.55e-05	0.000271	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—thyroid cancer	9.4e-05	0.000267	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—thyroid cancer	9.37e-05	0.000266	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—thyroid cancer	9.28e-05	0.000263	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—thyroid cancer	9.14e-05	0.000259	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—thyroid cancer	9.09e-05	0.000258	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—thyroid cancer	8.99e-05	0.000255	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—thyroid cancer	8.88e-05	0.000252	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—thyroid cancer	8.73e-05	0.000248	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—thyroid cancer	8.59e-05	0.000244	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—thyroid cancer	8.57e-05	0.000243	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—thyroid cancer	8.33e-05	0.000236	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—thyroid cancer	8.15e-05	0.000231	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—thyroid cancer	8.15e-05	0.000231	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—thyroid cancer	8.11e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—thyroid cancer	8.03e-05	0.000228	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—thyroid cancer	7.97e-05	0.000226	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—thyroid cancer	7.77e-05	0.00022	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—thyroid cancer	7.71e-05	0.000219	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—thyroid cancer	7.64e-05	0.000217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—thyroid cancer	7.49e-05	0.000212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—thyroid cancer	7.45e-05	0.000211	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—thyroid cancer	7.24e-05	0.000205	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—thyroid cancer	7.17e-05	0.000203	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—thyroid cancer	7.03e-05	0.000199	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—thyroid cancer	6.68e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—thyroid cancer	6.49e-05	0.000184	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—thyroid cancer	6.23e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—thyroid cancer	5.89e-05	0.000167	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—thyroid cancer	5.75e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—thyroid cancer	5.73e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—thyroid cancer	5.43e-05	0.000154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—thyroid cancer	5.3e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—thyroid cancer	5.25e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—thyroid cancer	4.89e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—thyroid cancer	4.8e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—thyroid cancer	4.68e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—thyroid cancer	4.68e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—thyroid cancer	4.32e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—thyroid cancer	4.03e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—thyroid cancer	3.58e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—thyroid cancer	3.42e-05	9.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—thyroid cancer	3.02e-05	8.57e-05	CbGpPWpGaD
